Research progress in substances related to hemolysis risk in glucose-6-phosphate dehydrogenase deficiency

doi:10.19803/j.1672-8629.20211165

Abstract

Abstract: Drug-induced hemolysis is one of the common causes of acute hemolysis in glucose-6-phosphate dehydrogenase deficiency (G6PDd). With the development and marketing of new drugs, cases of drug-induced hemolysis in G6PDd are increasing year by year. This paper lists and updates antibiotics, antivirals, antineoplastics, antipyretics, anti-inflammatory drugs, metabolic drugs, vasodilators, anaesthetics, antidotes, other drugs, herbs, plants, topical drugs, reagents, chemicals and food with hemolysis risk for G6PDd so as to facilitate clinical selection of treatments and warning and prevention of this disease.

Key words: glucose-6-phosphate dehydrogenase deficiency, hemolysis risk, methemoglobinemia, drugs, chemical, food

CLC Number:

R994.11

LI Jinying, SONG Hongjie, LI Jinqi, GU Haihui, QIAN Baohua. Research progress in substances related to hemolysis risk in glucose-6-phosphate dehydrogenase deficiency[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 110-116.

References

[1] RENARD D, ROSSELET A.Drug-induced hemolytic anemia: Pharmacological aspects[J]. Transfus Clin Biol, 2017, 24(3): 110-114.
[2] LUZZATTO L, ALLY M, NOTARO R.Glucose-6-phosphate dehydrogenase deficiency[J]. Blood, 2020, 136(11): 1225-1240.
[3] LI JY, LI JQ, QIAN BH, et al.Drug-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency: an update[J]. Chinese Journal of Pediatrics(中华儿科杂志), 2021, 59(6): 522-525
[4] BAIRD JK.8-aminoquinoline therapy for latent malaria[J]. Clin Microbiol Rev, 2019, 32(4) : e00011-e00019.
[5] ONORI ME, RICCIARDI TC, URBANI A, et al.Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review[J]. Mol Biol Rep, 2021, 48(3): 2973-2978.
[6] DAR SA, WAHID M, HAQUE S, et al.Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)[J]. Eur Rev Med Pharmacol Sci, 2020, 24(15): 7923-7924.
[7] LUZZATTO L, NANNELLI C, NOTARO R.Glucose-6-phosphate dehydrogenase deficiency[J]. Hematol Oncol Clin North Am, 2016, 30(2): 373-393.
[8] DYSOLEY L, KIM S, LOPES S, et al.The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians[J]. BMC Infect Dis, 2019, 19(1): 250-250.
[9] LACERDA MVG, LLANOS-CUENTAS A, KRUDSOOD S, et al.Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria[J]. N Engl J Med, 2019, 380(3): 215-228.
[10] BELFIELD KD, TICHY EM.Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency[J]. Am J Health Syst Pharm, 2018, 75(3): 97-104.
[11] BRANDT O, RIEGER A, GEUSAU A, et al.Peas, beans, and the pythagorean theorem- the relevance of glucose-6-phosphate dehydrogenase deficiency in dermatology[J]. J Dtsch Dermatol Ges, 2008, 6(7): 534-539.
[12] YOUNGSTER I, ARCAVI L, SCHECHMASTER R, et al.Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review[J]. Drug Saf, 2010, 33(9): 713-726.
[13] TANG MX, XIA S.Acute hemolytic anemia induced by tegafur, gimeracil and oteracil potassium capsules[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2012, 23(4): 240-242
[14] FEGHALY J, AL HOUT AR, MERCIECA BM. Aspirin safety in glucose-6-phosphate dehydrogenase deficiencypatients with acute coronary syndrome undergoing percutaneous coronary intervention[J]. BMJ Case Rep, 2017: bcr-2017-220483.
[15] MINUCCI A, DE LUCA D, TORTI E, et al.Acute haemolytic crisis due to concomitant presence of infection and possible altered acetaminophen catabolism in a Philipino child carrying the G6PD-Vanua Lava mutation[J]. Ann Clin Biochem, 2011, 48(Pt 3): 282-285.
[16] HAGAG AA, BADRAIA IM, ELFARARGY MS, et al.Study of glucose-6-phosphate dehydrogenase deficiency: 5 years retrospective egyptian study[J]. Endocr Metab Immune Disord Drug Targets, 2018, 18(2): 155-162.
[17] ROBINSON KM, YANG W, HAIDAR CE, et al.Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies[J]. Pharmacogenomics J, 2019, 19(3): 305-314.
[18] MANGANELLI G, FICO A, MARTINI G, et al.Discussion on pharmacogenetic interaction in G6PD deficiency and methods to identify potential hemolytic drugs[J]. Cardiovasc Hematol Disord Drug Targets, 2010, 10(2): 143-150.
[19] KHAN U, HADID T.Rush for G6PD![J]. Blood, 2016 128(23): 2742.
[20] GOI T, SHIONOYA Y, SUNADA K, et al.General anesthesia in a glucose-6-phosphate dehydrogenase deficiency child: a case report[J]. Anesth Prog, 2019, 66(2): 94-96.
[21] DEPTA A, ERD G, WERNER C.Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management[J]. Anaesthesist, 2005, 55: 550-554.
[22] REHMAN A, SHEHADEH M, KHIRFAN D, et al. Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man[J]. BMJ Case Rep, 2018: bcr-2017-223369.
[23] BALWANI MR, BAWANKULE CP, RAMTEKE V, et al.Methylene blue induced methemoglobinemia with acute kidney injury in a glucose-6-phosphateDehydrogenase-deficient patient[J]. Indian J Nephrol, 2017, 27(6): 465-467.
[24] FRANCIS RO, JHANG JS, PHAM HP, et al.Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks[J]. Vox Sang, 2013, 105(4): 271-282
[25] LEE SW, LAI NM, CHAIYAKUNAPRUK N, et al.Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review[J]. Br J Clin Pharmacol, 2017, 83(1): 172-179.
[26] LO YH, MOK KL. High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency[J]. Am J Emerg Med, 2020, 38(11): 2488.e3-2488.e5
[27] LAI S, HUANG YQ, LIU AQ, et al.Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: first report of two cases[J]. J Clin Pharm Ther, 2017, 42(6): 783-785.
[28] RAD S, RAMESHRAD M, HOSSEINZADEH H.Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review[J]. Iran J Basic Med Sci, 2017, 20(5): 516-529.
[29] ZEKAVAT OR, MAKAREM A, BAHRAMI R, et al.Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality[J]. Pediatric Health Med Ther, 2019, 10: 33-37.
[30] PERINET I, LIOSON E, TICHADOU L, et al.Hemolytic anemia after voluntary ingestion of henna (Lawsonia inermis) decoction by a young girl with G6PD deficiency[J]. Med Trop (Mars), 2011, 71(3): 292-294.
[31] ZUCCOTTI GV, REDAELLI F, GUALDI V, et al.Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin[J]. Ital J Pediatr, 2014, 40: 71.
[32] VIEILLE SL, LEFEBVRE DE, KHALID AF, et al.Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency[J]. Nutr Rev, 2019, 77(2): 96-106.
[33] EHELEPOLA N, ABAYAGUNAWARDANA AN, SUDUSINGHE TN.A vegetable-induced hemolytic crisis in a G6PD deficient person: a case report[J]. BMC Res Notes, 2018, 11(1): 179.
[34] BICHALI S, BRAULT D, MASSEROT C, et al.Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children[J]. Eur J Pediatr, 2017, 176: 1415-1418.